Anaphylactic Release of a Basophil Kallikrein-Like Activity. I. Purification and Characterization.

Journal of Clinical Investigation - United States
doi 10.1172/jci109483
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

Fatal Anaphylactic and Anaphylactic-Like Reactions

BMJ
1953English

Rhodobacter capsulatusDNA Topoisomerase I Purification and Characterization

Archives of Biochemistry and Biophysics
BiochemistryMolecular BiologyBiophysics
1999English

Purification and Characterization of a Vulnificolysin-Like Cytolysin Produced by Vibrio Tubiashii

Applied and Environmental Microbiology
Applied MicrobiologyBiotechnologyEcologyFood Science
2001English

Partial Purification and Characterization of a Peroxidase Activity From Human Placenta

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
1990English

Human Platelet Heparanase: Purification, Characterization and Catalytic Activity

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
1998English

Purification and Characterization of a Type-I Topoisomerase From Cultured Tobacco Cells

Plant Physiology
Plant ScienceGeneticsPhysiology
1990English

TSG-6 Potentiates the Antitissue Kallikrein Activity of Inter–α-Inhibitor Through Bikunin Release

American Journal of Respiratory Cell and Molecular Biology
Respiratory MedicinePulmonaryClinical BiochemistryCell BiologyMolecular Biology
2007English

Partial Purification and Characterization of a Trypsin-Like Proteinase From Rabbit Preimplantation Uterine Fluid

Biological Chemistry Hoppe-Seyler
1985English

Purification and Characterization of a Rice Class I Chitinase, OsChia1b, Produced inEsherichia Coli

Bioscience, Biotechnology and Biochemistry
Organic ChemistryApplied MicrobiologyMolecular BiologyBiochemistryAnalytical ChemistryMedicineBiotechnology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy